Galmed Pharmaceuticals Ltd. buy Barclays PLC
Start price
09.05.24
/
50%
€0.40
Target price
09.05.25
€78.88
Performance (%)
1516.16%
End price
10.05.25
-
Summary
This prediction is currently being closed. The BUY prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd. has seen massive gains of 1516.16%. Barclays_PLC has a follow-up prediction for Galmed Pharmaceuticals Ltd. where he still thinks Galmed Pharmaceuticals Ltd. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -0.347% | -0.149% | 29.643% |
| iShares Nasdaq 100 | -0.687% | 1.850% | 14.950% |
| iShares Nikkei 225® | -2.075% | 3.770% | 4.558% |
| iShares S&P 500 | 0.351% | 1.988% | 11.383% |
Comments by Barclays_PLC for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $83.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
24.02.25
24.02.25
€98.39
24.02.26
24.02.26
-
19.09.24
19.09.24
Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
08.08.24
08.08.24
€85.19
08.08.25
08.08.25
2270.37%
09.08.25
09.08.25